Zelalem Eshete

Array ( [id] => 6163803 [patent_doc_number] => 20110160449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'PROCESSES FOR THE PRODUCTION OF POLYMORPHIC FORMS OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 13/041346 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4906 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160449.pdf [firstpage_image] =>[orig_patent_app_number] => 13041346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725587 [patent_doc_number] => 08404704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Use of polymorphic forms of rifaximin for medical preparations' [patent_app_type] => utility [patent_app_number] => 13/041348 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12974 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13041348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973608 [patent_doc_number] => 20110152516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 13/041347 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5822 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152516.pdf [firstpage_image] =>[orig_patent_app_number] => 13041347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163802 [patent_doc_number] => 20110160448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 13/041332 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4950 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160448.pdf [firstpage_image] =>[orig_patent_app_number] => 13041332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567435 [patent_doc_number] => 20120330006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD OF MANUFACTURING EPSILON-CAPROLACTAM' [patent_app_type] => utility [patent_app_number] => 13/581777 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5877 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685096 [patent_doc_number] => 20130053380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease' [patent_app_type] => utility [patent_app_number] => 13/581961 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25984 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9711055 [patent_doc_number] => 08835626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Materials for organic electroluminescent devices' [patent_app_type] => utility [patent_app_number] => 13/636752 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11306 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990394 [patent_doc_number] => 20130217675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'PYRIDO [4,3-B] INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/579904 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67507 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516776 [patent_doc_number] => 20120316184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'NOVEL MICROBICIDES' [patent_app_type] => utility [patent_app_number] => 13/581272 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21191 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064956 [patent_doc_number] => 20110201805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 12/931961 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2103 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201805.pdf [firstpage_image] =>[orig_patent_app_number] => 12931961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214522 [patent_doc_number] => 20110136902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => '12-MEMBERED-RING MACROLACTAM DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/027603 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36832 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136902.pdf [firstpage_image] =>[orig_patent_app_number] => 13027603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510553 [patent_doc_number] => 20120309960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'MACROCYCLES AS FACTOR XIA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/577666 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995237 [patent_doc_number] => 08519122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Compositions and methods for modification of biomolecules' [patent_app_type] => utility [patent_app_number] => 13/024908 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31977 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13024908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503142 [patent_doc_number] => 20120302550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'SALTS AND POLYMORPHS OF 8-FLUORO-2--1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE' [patent_app_type] => utility [patent_app_number] => 13/522549 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 23986 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768126 [patent_doc_number] => 20120035227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'DEUTERIUM-ENRICHED IXABEPILONE' [patent_app_type] => utility [patent_app_number] => 13/020245 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3532 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035227.pdf [firstpage_image] =>[orig_patent_app_number] => 13020245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110097 [patent_doc_number] => 20110189129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'HEPATITIS C VIRUS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/013212 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32979 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189129.pdf [firstpage_image] =>[orig_patent_app_number] => 13013212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177666 [patent_doc_number] => 20110178065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'NOVEL CYP17 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/005646 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73910 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178065.pdf [firstpage_image] =>[orig_patent_app_number] => 13005646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442496 [patent_doc_number] => 20120259111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'SEVEN-MEMBERED RING COMPOUND AND PHARMACEUTICAL USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/518628 [patent_app_country] => US [patent_app_date] => 2010-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70640 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028645 [patent_doc_number] => 08143403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/977275 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32094 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143403.pdf [firstpage_image] =>[orig_patent_app_number] => 12977275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756876 [patent_doc_number] => 20120028966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/977197 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20058 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028966.pdf [firstpage_image] =>[orig_patent_app_number] => 12977197 [rel_patent_id] =>[rel_patent_doc_number] =>)